Researcher pieces together AML prognosis puzzle
Monday, October 15, 2012 - 15:00
in Biology & Nature
When patients suffering from acute myeloid leukemia (AML) express high levels of the gene, MN1, an already aggressive leukemia is accelerated and shortens survival time. While that’s a known fact, the mechanisms involved aren’t well understood -- which is why a researcher decided to take a closer look.